Institutional investors purchased a net $6.6 million shares of SYN during the quarter ended September 2014 and now own 18.70% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GREAT POINT PARTNERS LLC Bought 4.0 Million shares of Synthetic Biologics Inc
KNOLL CAPITAL MANAGEMENT LP Bought 2.0 Million shares of Synthetic Biologics Inc